Maraviroc: a coreceptor CCR5 antagonist for management of HIV infection Article (Faculty180)

cited authors

  • Yost, Raymond; Pasquale, Timothy R; Sahloff, Eric G

description

  • The mechanism of action, pharmacology, pharmacokinetics, clinical efficacy, drug interactions, adverse effects, dosage and administration, cost, and role in therapy of maraviroc are reviewed.

authors

publication date

  • 2009

published in

start page

  • 715

end page

  • 26

volume

  • 66